Video

Dr. Taylor Discusses the Management of Endometrial Cancer

Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses the management of endometrial cancer.

Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses the management of endometrial cancer.

One of the challenges in managing endometrial cancer is the high rate of comorbidities within the population, Taylor says. More than 80% of patients with endometrial cancer are obese, and there is a high instance of diabetes, cardiovascular disease, arthritis, and poor renal function. Taylor says that individualized treatment would be beneficial to these patients, considering the high rate of comorbidities and importance of quality-of-life.

There is a lack of quality-of-life and patient reported outcomes, Taylor adds. Currently, the survival benefits for this population is modest, but the treatment regimen can have a huge impact on a woman’s quality of life. Clinicians needs to work with patients to develop strategies that optimize their quality of life alongside treatment, Taylor says.

Related Videos
Kimberly Cannavale, MPH
Laurence Albigès, MD, PhD
Sattva S. Neelapu, MD
David L. Porter, MD
Suneel Kamath, MD
Craig E. Devoe, MD, MS
Yoshie Umemura, MD, division chief, Neuro-Oncology, William R. and Joan R. Shapiro Chair for Neuro-Oncology Research, associate professor, neurology, Barrow Neurological Institute, chief medical officer, Ivy Brain Tumor Center
Adam M. Burgoyne, MD, PhD, associate clinical professor, medicine, the University of California San Diego
Julia Foldi, MD, PhD
Joaquim Bellmunt, MD, PhD